Match Document Document Title
US20110201706 ISOCYANATE TRIMERISATION CATALYST SYSTEM, A PRECURSOR FORMULATION, A PROCESS FOR TRIMERISING ISOCYANATES, RIGID POLYISOCYANURATE/POLYURETHANE FOAMS MADE THEREFROM, AND A PROCESS FOR MAKING SUCH FOAMS  
The instant invention provides an isocyanate trimerisation catalyst system, a precursor formulation, a process for trimerising isocyanates, rigid foams made therefrom, and a process for making...
US20150141633 TRITERPENOID SAPOGENIN PRODUCTION IN PLANT AND MICROBIAL CULTURES  
The disclosure relates to a method for enhancing the biosynthesis and/or secretion of sapogenins in the culture medium of plant and microbial cell cultures. Further, the disclosure also relates to...
US20110256561 LIVER DISEASE MARKER, METHOD AND APPARATUS FOR MEASURING THE SAME, AND METHOD FOR ASSAYING PHARMACEUTICAL PREPARATION  
A normal person (i.e. a control) and liver diseases such as drug induced liver injury, an asymptomatic hepatitis B carrier, an asymptomatic hepatitis C carrier, chronic hepatitis B, chronic...
US20140041062 GENETICALLY ENGINEERED MOUSE MODEL FOR AUTISM SPECTRUM DISORDER HAVING DELETION OF SHANK2 GENE AND USE THEREOF  
The present disclosure relates to an ASD genetically engineered model carrying a deletion of Shank2 gene and having reduced NMDA receptor function. According to the present disclosure, genetically...
US20150057243 Compositions and Methods for the Inhibition of Methyltransferases  
Methods and compositions disclosed herein relate to detecting, analyzing, isolating and inhibiting methyltransferases, methyltransferase substrates, S-adenosyl-methionine-binding proteins and RNA,...
US20110229403 Gaseous Ammonia Removal System  
A system and method for passive capture of ammonia in an enclosure containing material that gives off ammonia. The invention allows for the passage of gaseous NH3 through microporous hydrophobic...
US20080161604 Acetyl L-Carnitine For Preventing Painful Peripheral Diabetic Neuropathy  
The use of acetyl L-carnitine, or of one of its pharmaceutically acceptable salts, is described for the preparation of a medicament useful for the prevention of painful peripheral neuropathy in...
US20120129929 COMPOUND USED TO PREVENT DISEASES CAUSED BY AQUAPORIN DEFICIENCY  
A compound used to prevent diseases caused by aquaporin deficiency, which is 18β-Glycyrrhetinic acid derivative. Said compound can not only prevent diseases caused aquaporin deficiency, but be...
US20090270651 Methanol carbonylation system having absorber with multiple solvent options  
A methanol carbonylation system 10 includes an absorber tower 75 adapted for receiving a vent gas stream and removing methyl iodide therefrom with a scrubber solvent, the absorber tower being...
US20120264603 ATTACHMENT AND RETENTION FORMULATIONS FOR BIOLOGICALLY ACTIVE ORGANIC COMPOUNDS  
The invention encompasses formulations for increased attachment and retention systems of biologically active organic compounds and methods for the preparation and use thereof.
US20120095143 DISPERSION AND RETRIEVAL OF DE-BUNDLED NANOTUBES  
A method for dispersing nanotubes, comprising forming a nanocomposite solution with associated nanotubes and nanoplatelets, mixing a surfactant to the nanocomposite solution, separating the...
US20140256984 DEVICES AND METHODS FOR CRYSTALLIZATION  
The invention in some aspects relates to devices and methods for nucleating crystals under controlled conditions. In some aspects of the invention, devices and methods are provided for continuous...
US20140221435 AMIDES AS MODULATORS OF SODIUM CHANNELS  
The invention relates to amide compounds of formula I and I′ or pharmaceutically acceptable salts thereof, useful as inhibitors of sodium channels: The invention also provides pharmaceutically...
US20110294741 USE OF COMPOUNDS IN THE TREATMENT OF TAU-INDUCED CYTOTOXICITIES  
The present invention relates to derivatives of L-Tyrosyl-L-Arginine and the use of said derivatives in the prevention and/or treatment of a tau-induced cytotoxicity.
US20150065554 NEUROFIBROMATOSES THERAPEUTIC AGENTS AND SCREENING FOR SAME  
Disclosed herein are methods of treating a patient at risk of developing or having a neurofibromatosis or a sporadic schwannoma. In exemplary embodiments, the method involves administering to a...
US20140275618 THERAPEUTIC COMPOUNDS AND METHODS OF USE  
Compounds and methods useful for chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, and multiple sclerosis.
US20140018424 PREVENTIVE EFFECT OF CITRULLINE ON THE SPONTANEOUS DEVELOPMENT OF TUMORS  
L-citrulline or a nutraceutically or pharmaceutically acceptable salt thereof for reducing the kinetics of tumour development or reduce the incidence of tumours in aged humans and animals.
US20120190693 Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof  
The present invention relates to novel “reverse amide” compounds comprising a zinc chelator group, and the use of such compounds in the inhibition of HDAC6 and in the treatment of various...
US20130261311 BIOTIN STANNANE FOR HPLC-FREE RADIOIODINATION  
The present teachings provide methods that enable the preparation and purification of radioiodinated vectors without the need for HPLC purification, as well as novel precursors which include...
US20120035394 PROCESS FOR THE RECOVERY OF BETAINES FROM ELECTRODIALYSIS WASTE STREAMS  
The present invention discloses a process for the recovery of betaines from electrodialysis (ED) waste streams, whereby said waste streams are treated with a pressure driven membrane process.
US20150218078 CHEMICAL INTERMEDIATES BY CATALYTIC FAST PYROLYSIS PROCESS  
In this invention, a portion of the products from a pyrolysis reactor are reacted in a process to form one or more chemical intermediates.
US20140107306 CHEMICAL INTERMEDIATES BY CATALYTIC FAST PYROLYSIS PROCESS  
In this invention, a portion of the products from a pyrolysis reactor are reacted in a process to form one or more chemical intermediates.
US20110028751 PERFLUORO SULFONYL HALIDES AND RELATED SPECIES AS POLYMER SUPPORT MODIFIERS  
Activated Supports, support-bound activators, strongly acidic supports, and silylating supports are provided; the activated support having the formula: wherein L is a linking group component; X is...
US20110054180 Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst  
This invention relates to the use of nano-organocatalysts, and, more specifically, to the use of magnetic nanomaterial-supported organocatalysts. It is an object of the present invention to...
US20110144382 ADVANCED CATALYSTS FOR FINE CHEMICAL AND PHARMACEUTICAL APPLICATIONS  
A catalyst comprising a plurality of support nanoparticles and a plurality of catalytic nanoparticles. At least one catalytic nanoparticle is bonded to each support nanoparticle. The catalytic...
US20140274954 Boron-Containing Diacylhydrazines  
The present disclosure provides boron-containing diacylhydrazines having Formula I: and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, and R5 are defined as...
US20120128593 USE OF A MAGNETIC RESONANCE IMAGING MEDIUM COMPRISING HYPERPOLARIZED 13C PYRUVATE FOR THE DETECTION OF INFLAMMATION OR INFECTION  
The invention relates to a method of 13C-MR imaging, 13C-MR spectroscopy and/or 13C-MR spectroscopic imaging of inflammation or infection using an imaging medium which comprises a hyperpolarized...
US20110190307 Assay  
The present invention provides zebrafish based methods for the identification of compounds potentially useful in the treatment of motor neuron degenerative diseases (MNDDs), compounds identified...
US20130059860 NAPHTHALENE CARBOXAMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS  
The present invention is directed to naphthalene carboxamide compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which...
US20140303338 PROCESS FOR PRODUCING ACROLEIN, ACRYLIC ACID AND DERIVATIVES THEREOF  
A process for producing acrolein, comprising: a glycerin dehydration step of conducting dehydration reaction of glycerin to obtain an acrolein-containing gas; a partial-condensation step of...
US20140314850 FUNCTIONALIZED NANODIAMONDS AS DELIVERY PLATFORMS FOR NUCLEIC ACIDS  
The present application relates to functionalized nanodiamonds, to complexes comprising a functionalized nanodiamond reversibly bound to a nucleic acid and to compositions comprising such...
US20130211106 PRODUCTION OF GRAPHENE AND NANOPARTICLE CATALYSTS SUPPORTED ON GRAPHENE USING MICROWAVE RADIATION  
Microwave irradiation is used to synthesize graphene and metallic nanocatalysts supported on graphene either by solid or solution phase. In solid phase methods, no solvents or additional reducing...
US20130203830 Compounds for Prevention of Cell Injury  
The invention is related to compounds for prevention of cell injury or protection of cells. The compounds are involved in the maintenance or the increase of hydrogen sulphide in cells, which...
US20150148419 METABOLITES OF (1R-TRANS)-N-[[2-(2,3-DIHYDRO-4-BENZOFURANYL)CYCLOPROPYL]METHYL]PROPANAMIDE  
Isolated metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]-me thyl]propanamide, methods for their use, and compositions containing the metabolites.
US20120107210 PROCESSES FOR PREPARING HIGHLY PURE LITHIUM CARBONATE AND OTHER HIGHLY PURE LITHIUM CONTAINING COMPOUNDS  
The invention generally relates to methods of selectively removing lithium from various liquids, methods of producing high purity lithium carbonate, methods of producing high purity lithium...
US20120100056 PROCESSES FOR PREPARING HIGHLY PURE LITHIUM CARBONATE AND OTHER HIGHLY PURE LITHIUM CONTAINING COMPOUNDS  
The invention generally relates to methods of selectively removing lithium from various liquids, methods of producing high purity lithium carbonate, methods of producing high purity lithium...
US20110200508 PROCESSES FOR PREPARING HIGHLY PURE LITHIUM CARBONATE AND OTHER HIGHLY PURE LITHIUM CONTAINING COMPOUNDS  
The invention generally relates to methods of selectively removing lithium from various liquids, methods of producing high purity lithium carbonate, methods of producing high purity lithium...
US20140275621 OXIDATION PROCESS  
A process utilizing nitric acid and oxygen as co-oxidants to oxidize aldehydes, alcohols, polyols, preferably carbohydrates, specifically reducing sugars to produce the corresponding carboxylic acids.
US20140131283 Multiple Uses of Amine Salts for Industrial Water Treatment  
A method for treating in an industrial water treatment system for at least two of metal corrosion inhibition, scale inhibition, suspended matter dispersion, biocide efficacy, or biofilm...
US20130261335 PROCESS FOR PRODUCING ALKYL METHACRYLATE  
An object of the present invention is to provide a process for producing methacrylic acid with good productivity over a long period of time. The present invention provides a process for producing...
US20150052806 Method for Producing Levulinic Acid from Lignocellulosic Biomass  
A method for producing levulinic acid from lignocellulosic biomass comprising hemicellulose including one or more six carbon chain compound precursors comprises the steps of hydrolyzing the...
US20130210915 ANTIVIRAL COMPOUNDS  
The present invention provides new antiviral compounds and pharmacological compositions comprising these new compounds and their use in the prophylaxis, prevention and treatment of viral...
US20150031764 SUGAR ESTER PERACID ON SITE GENERATOR AND FORMULATOR  
Methods and systems for on-site generation of peracid chemistry, namely peroxycarboxylic acids and peroxycarboxylic acid forming compositions, are disclosed. In particular, an adjustable biocide...
US20120322872 SUGAR ESTER PERACID ON SITE GENERATOR AND FORMULATOR  
Methods and systems for on-site generation of peracid chemistry, namely peroxycarboxylic acids and peroxycarboxylic acid forming compositions, are disclosed. In particular, an adjustable biocide...
US20150133686 MECHANICALLY STABLE HOLLOW CYLINDRICAL SHAPED CATALYST BODIES FOR GAS PHASE OXIDATION OF AN ALKENE TO AN UNSATURATED ALDEHYDE AND/OR AN UNSATURATED CARBOXYLIC ACID  
A hollow cylindrical shaped catalyst body for gas phase oxidation of an alkene to an α,β-unsaturated aldehyde and/or an α,β-unsaturated carboxylic acid comprises a compacted multimetal oxide...
US20120279570 SOLUBLE GRAPHENE NANOSTRUCTURES AND ASSEMBLIES THEREFROM  
Disclosed herein is a method for preparing large soluble graphenes. The method comprises attaching one or more hindering groups to the graphene, which can prevent face-to-face graphene stacking by...
US20140315965 BIS-(ARYL/HETEROARYL)-METHYLENE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE FOR TREATING CANCER  
The present disclosure relates to novel compounds having vitamin D receptor agonist and histone deacetylase inhibitory efficacy as well as methods for reducing or inhibiting the proliferation of...
US20150250217 SALTY TASTE-ENHANCING AGENT AND MANUFACTURING METHOD THEREFOR, AND SALTY TASTE-ENHANCING METHOD  
An object of the present invention is to provide a novel salty taste-enhancing agent and production method therefor, and salty taste-enhancing method for a food and beverage. As means for...
US20140044797 PROSTACYCLIN AND ANALOGS THEREOF ADMINISTERED DURING SURGERY FOR PREVENTION AND TREATMENT OF CAPILLARY LEAKAGE  
The present invention relates to the novel use of prostacyclin analogs for prevention and/or treatment of capillary leakage during surgery. The treatment of the present invention mediates discrete...
US20150210607 USE OF BYPRODUCT ACETIC ACID FROM OXIDATIVE METHODS OF MAKING ACRYLIC ACID AND/OR METHACRYLIC ACID  
Processes are described for improved utilization of the byproduct acetic acid universally produced in various oxidative processes for making acrylic acid and methacrylic acid, wherein at least a...